A DNA Firm That Caters to Police Just Bought a Genealogy Site
By Megan Molteni,
Wired
| 12. 09. 2019
Just two years ago, GEDmatch was still an obscure genealogy website, known only to a million or so hobbyist DNA sleuths looking to fill in their family trees. The site was free, public, and run by two guys with a knack for writing algorithms that helped relatives find each other. All in all, it was a pretty controversy-free place.
That all changed in April of 2018, when news broke that police had used GEDmatch to identify a suspect in the 40-year-old Golden State Killer case. As the site emerged as a crime-fighting tool, some users and privacy experts began to worry about how people’s genetic data might ensnare them in criminal investigations, when all they wanted was to learn about their family history. The transition has been rocky for GEDmatch. One drama after another has engulfed the website: Police searches have grown increasingly invasive; the site’s owners tried to react with changes to its terms of service that ended up backfiring; and white-hat hackers pointed out glaring security flaws. But starting Monday, that’s all someone else’s problem.
On Monday...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...